The global telehealth market is slated to reach USD 266.8 billion 2026, exhibiting a CAGR of 23.4% during the forecast period. One of the main drivers of this is the high prevalence of stark inequalities in rural healthcare, especially in developing and underdeveloped countries where majority of the population lives in villages. For example, the World Health Organization Health Report 2018 states that in 2015, 303,000 women died across the world due to poor pre and post- natal healthcare.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/telehealth-market-101065

Fortune Business Insights profiles some of the important participants in the telehealth market:

• Dictum Health, Inc.
• SnapMD, Inc.
• American Well
• MDLIVE Inc.
• GlobalMed
• Doctor on Demand, Inc.
• Encounter Telehealth
• Teledoc Health, Inc.

More importantly, 99% of these deaths occurred in low and middle-income countries; 64% of those happened in Sub-Saharan Africa. This situation is a result of low levels of socio-economic development, owing to which governments in these countries are unable to bring modern healthcare facilities to the rural poor. This is where telehealth services can come to the fore and many governments today are utilizing them to improve health of their citizens.

According to the report by Fortune Business Insights, titled “Telehealth Market Size, Share and Industry Analysis By Type (Products, Services), By Application (Telemedicine, Patient Monitoring, Continuous Medical Education, Others), By Modality (Store-and-forward (Asynchronous), Real-time (Synchronous), Remote Patient Monitoring), By End User (Healthcare Facilities, Homecare, Others), and Geography Forecast, 2019 – 2026”, the value of this market in 2018 was USD 49.8 billion. The report further provides a detailed analysis of the factors that will play an influential role in the development of the Telehealth market. A comprehensive evaluation of the trends, dynamics, and industry outlook is also contained in the report.

Company Collaborations Are Proving Chief Growth Drivers

Due to the increasing demand, telehealth market companies are adopting collaborative strategies with the aim of expanding business on a global scale. Furthermore, leading companies in the telehealth industry are focusing on mergers and acquisitions to gain competitive strength. Companies are trying to incorporate modern industrial concepts with a view to gain more end users. Fortune Business Insights expects market collaborations will help companies generate substantial telehealth market revenue.

In April 2018, American Well acquired Avizia Limited with the aim of strengthening its position among the companies in the telehealth industry. American Well’s acquisition of Avizia will help the company take a big leap in the telehealth market, owing to the exceptional portfolio of telehealth services bolstered by Avizia. The report includes company mergers, similar to American Well’s latest acquisition and signifies the impact of such M&As on the global telehealth market.

According to the World Bank, approximately 84% populace in Germany depend on Internet and around 75% populace in the U.S. are subscribers of the Internet, which augments the global ePharmacy market growth. Fortune Business Insights states that the global ePharmacy market is projected to reach US$ 177,794.9 Mn by 2026, thereby exhibiting an impressive CAGR of 17.3% during the forecast period (2019-2026). The company further states that the global market was valued at US$ 49,727.7 Mn in 2018. According to a published report by Fortune Business Insights, titled, “ePharmacy: Global Market Analysis, Insights and Forecast, 2019-2026,” the global ePharmacy market will witness notable growth during the forecast period due to the technological advancements based on artificial intelligence.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/epharmacy-market-100238

Fortune Business Insights has profiled some of the prominent market players operating in the global ePharmacy market. They are as follows:

• DocMorris
• CVS Health Corporation
• Express Script Holding Company
• Walgreen Co.
• Optum Rx, Inc.
• Giant Eagle, Inc.
• Walmart Stores, Inc.
• Rowland Pharmacy
• The Kroger Co.
• Other players

Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies. Also, increasing usage of smartphones and high speed of the Internet are expected to aid North America in gaining the highest global ePharmacy market share in the forthcoming years. Furthermore, a rise in geriatric population, increasing online orders, and growing adoption of online platforms will drive the market growth in this region.

Europe and Asia Pacific, on the other hand, are projected to exhibit significantly high CAGR during the forecast period. In Europe, numerous prominent market players have begun offering products at lucrative rates. This will positively impact growth of ePharmacy market in this region. Asia Pacific, on the other hand, has been witnessing higher adoption of e-commerce websites and increasing patient pool. Moreover, the healthcare infrastructure in this region is on the verge of becoming prosperous. All these factors are anticipated to fuel ePharmacy market growth in Asia Pacific in the coming years.

The global telehealth market is slated to reach USD 266.8 billion 2026, exhibiting a CAGR of 23.4% during the forecast period. One of the main drivers of this is the high prevalence of stark inequalities in rural healthcare, especially in developing and underdeveloped countries where majority of the population lives in villages. For example, the World Health Organization Health Report 2018 states that in 2015, 303,000 women died across the world due to poor pre and post- natal healthcare.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/telehealth-market-101065

Fortune Business Insights profiles some of the important participants in the telehealth market:

• Dictum Health, Inc.
• SnapMD, Inc.
• American Well
• MDLIVE Inc.
• GlobalMed
• Doctor on Demand, Inc.
• Encounter Telehealth
• Teledoc Health, Inc.

More importantly, 99% of these deaths occurred in low and middle-income countries; 64% of those happened in Sub-Saharan Africa. This situation is a result of low levels of socio-economic development, owing to which governments in these countries are unable to bring modern healthcare facilities to the rural poor. This is where telehealth services can come to the fore and many governments today are utilizing them to improve health of their citizens.

According to the report by Fortune Business Insights, titled “Telehealth Market Size, Share and Industry Analysis By Type (Products, Services), By Application (Telemedicine, Patient Monitoring, Continuous Medical Education, Others), By Modality (Store-and-forward (Asynchronous), Real-time (Synchronous), Remote Patient Monitoring), By End User (Healthcare Facilities, Homecare, Others), and Geography Forecast, 2019 – 2026”, the value of this market in 2018 was USD 49.8 billion. The report further provides a detailed analysis of the factors that will play an influential role in the development of the Telehealth market. A comprehensive evaluation of the trends, dynamics, and industry outlook is also contained in the report.

Preference for Online Consultation to Favour the Telehealth Market in North America

Among regions, North America is expected to dominate the global telehealth market share during the forecast period. The main factors driving the market in the region is the increasing inclination towards online medical consultation and a well-established healthcare insurance system in the continent. Rising popularity of wearable devices is anticipated to be the primary force behind the telehealth market growth in Europe. In Asia-Pacific, government schemes and increasing investment in healthcare brings good news for the market in the forecast period. Increasing healthcare spending in the Middle East and high concentration of population in rural areas will be the main factors augmenting the telehealth market growth till 2026.

Strategic Collaborations to Make Competition Dynamic

Key players are entering into partnerships to strengthen their position in the market and diversify their product portfolio. For example, in October 2019, Doctor on Demand announced that they were joining hands with Walmart to provide quality and low-cost virtual primary care to Walmart associates based in different US states. Similarly, Comcast partnered with Independent Health Group in April 2018 to develop a unique communication and patient care platform.

Fortune Business Insights offers a detailed overview of the global market in a report, titled “Wearable Medical Devices Market” Size, Share and Industry Analysis by Product (Diagnostic & Patient Monitoring, Therapeutic), By Application (Remote Patient Monitoring and Home Healthcare, Sports and Fitness), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hypermarkets) and, Regional Forecast 2019-2026.” As per the report, the market was valued at USD 24571.8 Million in 2018 and is anticipated to reach USD 139353.6 Million by 2026. The report offers a comprehensive overview of the market drivers, trends, opportunities, and other aspects of the market.

To Gain More Insights into the Market, Click Here: https://www.fortunebusinessinsights.com/industry-reports/wearable-medical-devices-market-101070

List Top Companies Covered in Wearable Medical Devices Market are

• Ypsomed AG
• Sonova
• Hologic Inc.
• Siemens Healthcare GmbH
• AiQ Smart Clothing
• NeuroMetrix, Inc.
• Apple Inc.
• SAMSUNG
• Fitbits
• SugarBeat

The global wearable medical devices market is anticipated to exhibit an exponential CAGR of 24.7% through the forecast years. The healthcare industry is revolutionizing owing to the rising adoption of connected devices. As digital technology is gaining immense popularity, wearable medical devices are evolving rapidly in the healthcare sector.

Moreover, the objective of these devices is to not only promote the overall body fitness but to offer active treatment regarding health conditions. From Fitbit to smartwatches, the market is increasingly driven by technological developments with focus on personalized care. Taking about personalized care, technologies such as internet of things (IoT), cloud computing, and others help in retrieving patient data in real-time, thereby allowing physicians to detect the patient’s health condition in advance.

Rising Importance on Reducing Patient Hospital Stays to Encourage Growth in Asia Pacific Wearable Medical Devices Market

Considering regions, North America is expected to register high growth in the global wearable devices market during the forecast period. In 2018, the market was valued at USD 10146.3 Million. The evolving patient shift towards remote monitoring from traditional is increasing the adoption of wearable devices in this region. The implementation of favourable regulatory policies for the development of smart and advanced wearable devices is another factor driving the market in this region. This, coupled with the rising adoption of advanced healthcare infrastructure, is expected to enable growth in the market.

The Global Diabetes Devices Market is anticipated to exhibit an impressive CAGR of 5.5% on account of rising prevalence of diabetes. Key insights into this fast growing market, valued at US$ 32,441.3 mn in 2018, have been shared by Fortune Business Insights in its report, titled “Diabetes Devices Market Size, Share and Global Trend By Product (Monitoring Devices, Treatment Devices), By Distribution Channel (Institutional Sales, Retail Sales) and Geography Forecast till 2026”. The report brings out the key aspects that will influence the market in the forecast period. Diabetes is a metabolic disease in which the body is unable to process glucose, leading to elevated levels of blood sugar. This happens as the body does not make enough insulin (a hormone made by the pancreas), which helps the glucose enter the cells and supply the body with energy to function. Diabetes devices such as insulin pumps and continuous glucose monitors are used by medical professionals and patients to regulate and monitor blood glucose levels.

Browse Complete Report Details@

https://www.fortunebusinessinsights.com/industry-reports/diabetes-devices-market-100803

key industry developments

• In September 2018, DiaMonTech GmbH, in, launched a shoebox-sized device that can diagnose the blood glucose levels by using an infrared light beam through the skin.
• In February 2019, Tandem Diabetes Care, Inc., received FDA approval for the marketing of the first insulin pump with interoperable technology for children and adults with diabetes. t: Slim X2 insulin pump is the first device to be classified under a new de novo premarket review pathway.
• In July 2019, F. Hoffmann-La Roche Ltd. received safety approval for the launch of the Accu-Chek Solo insulin patch pump and wireless touchscreen handheld in Europe.

Increasing Incidence of Diabetes to Fuel the Market

The International Diabetes Foundation has estimated that by 2040, the number of people affected by diabetes will reach 642 million. Diabetes is a lifelong condition and an increasing prevalence of the disease bodes well for the global diabetes devices market. Increasing sedentary lifestyles, lack of exercise, obesity, excessive consumption of fatty and sugar-laced food, and rising stress levels are enhancing the risk of diabetes among people. The market size is expected to expand as novel devices are introduced in the market such as wearable glucose monitoring devices and smart insulin pumps. This expansion will happen on account of rising demand for non-invasive techniques to monitor and regulate blood sugar levels in real-time.

Additionally, aging populations are increasing in the world, especially the western countries, and the incidence rate of Type 2 diabetes is expected to rise in tandem. This factor will be a major booster for the global diabetes devices market in the forecast period. 

Certain Misgivings May Restrain Market Growth

The global diabetes devices market is expected to grow on the basis of steadily rising adoption rates of various monitoring devices. However, certain devices entail a few risks, which may cast a shadow of doubt in the minds of consumers. For example, insulin pumps are very convenient and efficient way to administer the required amount of insulin into the body. But, there is a fear that patients might get infected at the catheter site. Insulin pumps are also expensive, which can push people to avail traditional methods of diabetes care. Similarly, continuous glucose monitors (CGMs) are known to be inaccurate, especially in case of drop in glucose levels. This is mainly because the technology is still developing. CGMs are also known to be expensive.

The Global Pulse Oximeters Market is likely to grow in the coming years due to increasing usage clearances from the Food and Drug Administration (FDA). According to a report published by Fortune Business Insights, titled “Pulse Oximeters: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to reach US$ 2,657.6 Mn by the end of 2025. Fortune Business Insights states that the market was valued at US$ 1,587.3 Mn in 2017 and will exhibit a CAGR of 6.7% in the forecast period.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/pulse-oximeters-market-100528

Some of the Main Key Players Covered in the Report

• Omron Healthcare, Inc.
• Philips Benelux
• General Electric Manufacturing Company (GEMAC)
• Masimo
• Messe Düsseldorf GmbH
• Vyaire Medical
• Opto Circuits India Ltd.
• Medtronic
• Nonin Medical, Inc

Masimo’s Approval for Radius PPG to Trigger Growth

In 2019, Masimo received clearance for its latest pulse oximeter. The ‘Radius PPG’ was approved by the FDA after establishing efficient results through clinical trials. The Radius PPG represents a significant breakthrough in the healthcare industry, particularly for the diagnosis and study of oxygen levels in the blood. The wireless ability allows users to move freely even when they are being examined with the device.

iHealth’s Wristworn Pulse Oximeter to Witness Massive Demand

iHealth’s wrist-worn pulse oximeter’s wide end user coverage can be attributed to its clinical efficacy and most importantly, its ease of use. The device is available on e-commerce websites such as Amazon and the ease of availability for iHealth’s latest device is a leading factor that has contributed to the growth of the global market.

The device can continuously monitor blood oxygen saturation levels along with the pulse rate, both within a short span of time. The device is integrated with a LED display that shows the oxygen saturation readings. The device operated through the emission of infrared light onto the blood vessels of the fingertip. The device has won over many users and the increasing demand has led to the distribution on online retail chains as well as offline stores. iHealth’s latest device is likely to boost the global pulse oximeter market in the forthcoming years.

The global orthopedic implants market size is set to touch USD 64.0 billion by 2026, exhibiting a modest CAGR of 4.1% during the forecast period. Unprecedented rise in geriatric population across the globe to be the key growth driver of this market. According to the United States Census Bureau (USCB), the proportion of aged people to the total world population is steadily climbing. For example, in 2012, world population had reached 7 billion and the people aged 65 and above were 8% of this number or 562 million.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/orthopedic-implants-market-101659

Some of the key players in this market include:

• BioTek Instruments, Inc.
• Zimmer Biomet
• Integra LifeSciences Corporation
• DePuy Synthes Companies (Johnson & Johnson Services, Inc.)
• ArthroCare Corporation
• Medtronic
• CONMED Corporation
• Smith & Nephew

In 2015, the number rose by 55 million, with the percentage increasing to 8.5% of the total population in a span of 3 years. The USCB predicts that between 2025 and 2050, this geriatric population will double to reach 1.6 billion, whilst the total population will grow only by 34%.

This, the USCB states, is attributable to the reduction in fertility rates around the world and lengthening lifespans due to advancements in medical technologies. This is expected to substantially broaden the base of the market, especially the joint reconstruction segment, as per the orthopedic implants market trends.

Widespread Prevalence of Musculoskeletal Conditions to Spike Market Demand

Musculoskeletal conditions refer to disorders that adversely affect the locomotor system in the body, that is, bones, muscles, joints, ligaments, and tissues. Disorders related to these movements are increasing in prevalence, as stated by the World Health Organization (WHO). According to the WHO, between 20% and 33% of the world’s population is currently suffering from some painful and chronic musculoskeletal disease. The 2017 Global Burden of Disease Report revealed that musculoskeletal conditions were the second leading contributor to global disability, accounting for about 16% of all years with disability in an individual’s life. Given the economic costs associated with these disorders, the need to prevent them is stronger than ever today, which augurs well for the market as it will spur innovation among players in the forecast period.

North America to Hold a Commanding Position; Europe to Grow at an Impressive Rate

Among regions, North America is expected to dominate the global orthopedic implants market share owing to the increasing incidence of osteoarthritis in the region. Europe is projected to grow at a considerable rate on account of rapid spread of chronic diseases such as diabetes and obesity in the continent. In Asia-Pacific, rise in healthcare expenditure and increasing disposable incomes will propel the market in the region, as per the orthopedic implants market analysis by Fortune Business Insights. However, the market growth in Africa, Latin America, and the Middle East is anticipated to be slow due to low levels of development in these regions.

The rising prevalence of unwanted pregnancies is boosting the global contraceptive drugs market. In a report, titled “Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025” Fortune Business Insights identifies various factors enabling growth in the market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-drugs-market-100063

Leading Players operating in the Contraceptive Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Bayer AG

• Pfizer Inc.
• Janssen Global Services, LLC
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.
• Mylan N.V.
• Allergan Plc
• Agile Therapeutics
• Piramal Enterprises Ltd.

According to the report, the global contraceptive drugs market is anticipated to rise at 5.8% CAGR and reach a value of US$ 20,200.5 Mn by 2025 from US$ 13,097.7 Mn in 2017. Remarkably improving access to contraceptive pills around the world is a key factor propelling growth in this market.

Rising Abortion Rates to Create Demand for Contraceptive Drugs

Under the Affordable Care Act (ACA) in the U.S., oral contraceptive pills are given free of cost to women in the U.S. Such regulations favor the growth of the contraceptive drugs market. Increasing government initiatives to reduce infant mortality due to early pregnancies will increase the demand for oral contraceptives. Contraceptive drugs not only help to control unwanted pregnancies but also reduce the number of abortion and complications associated with the procedure worldwide. As per the World Health Organization, there is an estimated 40 to 50 million abortions every year, corresponding to an approximate of 125,000 abortions per day. To avoid unwanted and unplanned pregnancies, an increasing number of women are opting for contraceptive drugs. This will in turn augment growth in the global market.

Contrary to this, the market for contraceptive drugs may face challenges posed by religious, ethical, and social barriers especially in more conservative regions. Social taboos often discourage the use of contraceptive drugs among women, subsequently adversely impacting the overall market.

Government Initiatives to Promote Use of Contraceptive Medicines

Geographically, North America held dominance in the global contraceptive drugs market owing to the presence of leading players in the region. This, accompanied with easy availability of contraceptive drugs, has catapulted North America to the fore of the global market. However, Asia Pacific is most likely to emerge as the fastest growing region. This is owing to government initiatives adopted across emerging nations of this region. These initiatives are intended at promoting the use of contraceptive medicines as a convenient way of preventing unwanted pregnancy.

The global genomics market size is projected to reach USD 62614.6 million by 2026. Genomics has successfully transformed the way of preventing, managing and treating diseases. Researchers at the University of Paris-Saclay believe that we have entered into the third revolution of sequencing technology in the world of genetics. Moreover, several companies are planning to build third-generation sequencing technology to stay abreast of new trends. As per a recent report published by Fortune Business Insights, titled “Genomics Market Size, Share and Industry Analysis By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Regional Forecast, 2019 – 2026,” the market value stood at USD 15888.8 million in 2018 and is anticipated to exhibit an exponential CAGR of 18.7% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Some of the other leading players operating in the global market are:

• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies
• Danaher
• QIAGEN
• BGI
• IntegraGen

The genomics market report outlines the present and future scenario of the market by offering key insights into the trends and drivers stimulating growth. Furthermore, it highlights detailed information on several aspects of the market which include opportunities, challenges, and threats. The report throws lights on the competitive landscape by covering key developments of some of the leading players. It also highlights strategies adopted by players, which in turn, can help stakeholders to make business decisions. Further to this, it also showcases information on all the major segments and their respective market share.

Advancements in Bioinformatics to Boost the Market in North America

Among regions, North America is anticipated to emerge dominant in the global genomics market throughout the forecast years. In 2018, the market value stood at USD 6959.3 million. This is ascribable to the rising focus on pharmacogenomics and technological advancements in bioinformatics. This, coupled with increasing adoption of new sequencing technologies, will create growth opportunities for the market in this region. Rising preference for personalized medicines is another factor responsible for the dominance of market in this region.

Start-ups to Focus on Providing Genomics Services to Customers

Veritas Genomics announced the launch of new genome sequencing products in November 2018. The company aims to enhance its customer service and expand its product portfolio. Other companies such as Agilent Technologies, Inc., Illumina, Inc., and F. Hoffmann-La Roche Ltd are expected to lead the market in the forecast period. This is mainly on account of their strong product portfolio and wide geographical reach

According to the World Bank, approximately 84% populace in Germany depend on Internet and around 75% populace in the U.S. are subscribers of the Internet, which augments the global ePharmacy market growth. Fortune Business Insights states that the global ePharmacy market is projected to reach US$ 177,794.9 Mn by 2026, thereby exhibiting an impressive CAGR of 17.3% during the forecast period (2019-2026). The company further states that the global market was valued at US$ 49,727.7 Mn in 2018. According to a published report by Fortune Business Insights, titled, “ePharmacy: Global Market Analysis, Insights and Forecast, 2019-2026,” the global ePharmacy market will witness notable growth during the forecast period due to the technological advancements based on artificial intelligence.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/epharmacy-market-100238

Fortune Business Insights has profiled some of the prominent market players operating in the global ePharmacy market. They are as follows:

• DocMorris
• CVS Health Corporation
• Express Script Holding Company
• Walgreen Co.
• Optum Rx, Inc.
• Giant Eagle, Inc.
• Walmart Stores, Inc.
• Rowland Pharmacy
• The Kroger Co.
• Other players

Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies. Also, increasing usage of smartphones and high speed of the Internet are expected to aid North America in gaining the highest global ePharmacy market share in the forthcoming years. Furthermore, a rise in geriatric population, increasing online orders, and growing adoption of online platforms will drive the market growth in this region.

Key Market Players to Focus on Bagging Funds for Expanding Online Platforms

Several key market players operating in the global ePharmacy market have begun exploring and implementing new strategies to provide the consumers with smooth service. Fortune Business Insights has listed a few key developments that have occurred in the global ePharmacy market since the past few years:

• Meds, a Swedish online pharmacy announced in January 2019 that it raised US$ 5.5 million in a funding round conducted by Inbox Capital, a family-owned venture capital company, headquartered in Sweden. The total amount of the startup has increased to US$ 10.5 million. Meds sells healthcare, beauty products, prescription, and non-prescription drugs. They have received permission from the Swedish Medical Product Agency to sell those. According to the company, approximately 40% of the sales come from the households in the Stockholm area as the home delivery service takes less than two hours. After receiving the funds, the company declared that it would soon expand their area of delivery to both Gothenburg and Malmö. Also, the company has planned to expand its warehouse area.